Bacteremias by Acinetobacter spp. and carbapenems resistance

被引:0
|
作者
Hernan Rodriguez, Carlos [1 ]
Nastro, Marcela [1 ]
Weyland, Beatriz [1 ]
Losada, Mirta [1 ]
Vay, Carlos [1 ]
Famiglietti, Angela [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Bacteriol Lab, Dept Bioquim Clin,Hosp Clin Jose de San Martin, RA-1120 Buenos Aires, DF, Argentina
来源
关键词
Acinetobacter; carbapenems resistance; critical care; bloodstream; risk factors; PSEUDOMONAS-AERUGINOSA; RISK-FACTORS; BAUMANNII; TIGECYCLINE; EMERGENCE; COLISTIN;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The incidence, risk factors and susceptibility of Acinetobacter bacteremia in patients from Hospital de Clinicas, University of Buenos Aires, were retrospectively analysed. One hundred and one patients were evaluated between 2002 and 2008. An increasing resistance to carbapenem in bacteremia was observed, rising from 50% in 2002 to 70% in 2007-2008. Significative risk factors for the acquisition of imipenem resistance Acinetobacter bacteremia included: previous use of imipenem (p<0.05), intensive care units stay (p<0.05), and polimicrobial bloodstream (p<0.05). Minocycline, tigecycline and colistin were active in all strains whereas sulbactam, cefepime, amikacin, gentamicin and levofloxacin showed a better activity among imipenem-susceptible isolates.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [1] Antimicrobial Resistance in Acinetobacter spp. and Pseudomonas spp.
    Lupo, Agnese
    Haenni, Marisa
    Madec, Jean-Yves
    [J]. MICROBIOLOGY SPECTRUM, 2018, 6 (03):
  • [2] Susceptibility of Acinetobacter spp. to antimicrobial agents with respect to their susceptibility to carbapenems
    Sredkova, M.
    Mihaylova, S.
    Edreva, V.
    Pachkova, S.
    Grigorova, V.
    Hitkova, H.
    Popova, V.
    Dragoev, K.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S468 - S468
  • [3] Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in an UK burns unit
    Weinbren, MJ
    Johnson, AP
    Kaufmann, ME
    Livermore, DM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (05) : 574 - 576
  • [4] Antimicrobial resistance of Acinetobacter spp. in Europe
    Falagas, ME
    Kasiakou, SK
    Michalopoulos, A
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (12) : 1106 - 1107
  • [5] Antimicrobial resistance of Acinetobacter spp. in Europe
    Van Looveren, M
    Goossens, H
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (08) : 684 - 704
  • [6] Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.
    Poirel, Laurent
    Figueiredo, Samy
    Cattoir, Vincent
    Carattoli, Alessandra
    Nordmann, Patrice
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1252 - 1256
  • [7] Clinical importance and antibiotic resistance of Acinetobacter spp.
    Towner, KJ
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1997, 46 (09) : 721 - 746
  • [8] Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp.
    Seward, RJ
    Lambert, T
    Towner, KJ
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (05) : 455 - 462
  • [9] Rapid Determination of Quinolone Resistance in Acinetobacter spp.
    Hujer, Kristine M.
    Hujer, Andrea M.
    Endimiani, Andrea
    Thomson, Jodi M.
    Adams, Mark D.
    Goglin, Karrie
    Rather, Philip N.
    Pennella, Thuy-Trang D.
    Massire, Christian
    Eshoo, Mark W.
    Sampath, Rangarajan
    Blyn, Lawrence B.
    Ecker, David J.
    Bonomo, Robert A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (05) : 1436 - 1442
  • [10] Resistance analysis of Acinetobacter spp. by DNA-microarrays
    Dally, S.
    Bailer, S. M.
    Rupp, S.
    Knabbe, C.
    Weile, J.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 93 - 93